-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial

Dow Jones·10/29/2026 11:00:00

Please log in to view news